» Articles » PMID: 31849219

β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs

Overview
Journal ACS Sens
Specialty Biotechnology
Date 2019 Dec 19
PMID 31849219
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

β-Arrestins are critical regulators of G protein-coupled receptors (GPCRs) that desensitize G protein signaling, promote receptor internalization, and initiate signaling on their own. Recent structural findings indicate that β-arrestins adopt different conformations upon interaction with agonist-activated GPCRs. Here, we established a β-arrestin-2 conformational bioluminescence resonance energy transfer (BRET) sensor composed of the bright Nanoluc BRET donor and the red-shifted CyOFP1 BRET acceptor. The sensor monitors early intramolecular conformational changes of β-arrestin-2 in complex with a wide panel of different class A and class B GPCRs upon agonist activation and with orphan GPCRs known to spontaneously recruit β-arrestin-2. The introduction of the R170E mutant in the β-arrestin-2 sensor allowed the detection of a partially active β-arrestin-2 conformation, which is not dependent on receptor phosphorylation, while the deletion of the β-arrestin-2 finger-loop region detected the "tail-conformation" corresponding to the interaction of β-arrestin with the carboxyl-terminal domain of GPCRs. The new sensors combine the advantages of the BRET technique in terms of sensitivity, robustness, and suitability for real-time measurements with a high responsiveness toward early conformational changes to help to elucidate the different conformational states of β-arrestins associated with GPCR activation in living cells.

Citing Articles

Electrically Driven, Bioluminescent Compliant Devices for Soft Robotics.

Kusama K, Oishi A, Ueno H, Yoshimi A, Nagase M, Shintake J ACS Appl Mater Interfaces. 2025; 17(7):11248-11258.

PMID: 39930615 PMC: 11843531. DOI: 10.1021/acsami.4c18209.


Upregulation of Piezo2 and increased extracellular matrix protein in diabetic kidney disease mice.

Oba R, Ueno H, Oishi A, Nagahama K, Kanzaki G, Tsuboi N Hypertens Res. 2025; .

PMID: 39833555 DOI: 10.1038/s41440-024-02082-y.


Quantitative approaches for studying G protein-coupled receptor signalling and pharmacology.

Pearce A, Redfern-Nichols T, Wills E, Rosa M, Manulak I, Sisk C J Cell Sci. 2025; 138(1).

PMID: 39810711 PMC: 11828474. DOI: 10.1242/jcs.263434.


Investigating G-protein coupled receptor signalling with light-emitting biosensors.

Demby A, Zaccolo M Front Physiol. 2024; 14:1310197.

PMID: 38260094 PMC: 10801095. DOI: 10.3389/fphys.2023.1310197.


Detecting and measuring of GPCR signaling - comparison of human induced pluripotent stem cells and immortal cell lines.

Chen G, Obal D Front Endocrinol (Lausanne). 2023; 14:1179600.

PMID: 37293485 PMC: 10244570. DOI: 10.3389/fendo.2023.1179600.